Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
August 1, 1991
Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion
W Ko, A S Hawes, W D Lazenby, et al.
The Annals of Thoracic Surgery
|
August 1, 1997
Aortic atheroma is related to outcome but not numbers of emboli during coronary bypass
D Barbut, Y W Lo, G S Hartman, et al.
Journal of Cardiac Failure
|
March 31, 2009
Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36
Phyllis G Supino, Jeffrey S Borer, Joseph A Franciosa, et al.
Circulation
|
March 11, 1998
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance
J S Borer, C Hochreiter, E M Herrold, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 25, 1998
Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements
T K Rosengart, W DeBois, M O'Hara, et al.
The Annals of Thoracic Surgery
|
November 1, 1996
Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding
R E Helm, J D Klemperer, T K Rosengart, et al.
The Annals of Thoracic Surgery
|
February 10, 1998
Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion
R E Helm, T K Rosengart, M Gomez, et al.
Human Gene Therapy
|
June 12, 1999
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121
S R Patel, L Y Lee, C A Mack, et al.
Human Gene Therapy
|
January 1, 1997
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype
C A Mack, W R Song, H Carpenter, et al.
The Annals of Thoracic Surgery
|
February 2, 2000
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
L Y Lee, S R Patel, N R Hackett, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
The Journal of Thoracic and Cardiovascular Surgery
|
August 1, 1991
Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion
W Ko, A S Hawes, W D Lazenby, et al.
The Annals of Thoracic Surgery
|
August 1, 1997
Aortic atheroma is related to outcome but not numbers of emboli during coronary bypass
D Barbut, Y W Lo, G S Hartman, et al.
Journal of Cardiac Failure
|
March 31, 2009
Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36
Phyllis G Supino, Jeffrey S Borer, Joseph A Franciosa, et al.
Circulation
|
March 11, 1998
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance
J S Borer, C Hochreiter, E M Herrold, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 25, 1998
Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements
T K Rosengart, W DeBois, M O'Hara, et al.
The Annals of Thoracic Surgery
|
November 1, 1996
Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding
R E Helm, J D Klemperer, T K Rosengart, et al.
The Annals of Thoracic Surgery
|
February 10, 1998
Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion
R E Helm, T K Rosengart, M Gomez, et al.
Human Gene Therapy
|
June 12, 1999
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121
S R Patel, L Y Lee, C A Mack, et al.
Human Gene Therapy
|
January 1, 1997
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype
C A Mack, W R Song, H Carpenter, et al.
The Annals of Thoracic Surgery
|
February 2, 2000
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
L Y Lee, S R Patel, N R Hackett, et al.
Page
of 13